Bridging Communities to Improve Dementia Outcomes

In collaboration with:
 

With the current ageing population, dementia is becoming more prevalent and it is estimated that by 2025, around 1 million people in the UK will have dementia.  It is time to coordinate how we can maximise outcomes for patients, carers, health and social care systems to better identify at risk individuals to help delay onset and impact of disease, manage symptoms, discover and develop new treatments and help patients maintain their independence.

This evening’s meeting will bring together presentations from innovative approaches spanning diagnostics, drug development, medtech and digital technologies to apply to the multidisciplinary prevention and care of dementia patients. It should appeal to anyone within these sectors with an interest in dementia research or enthusiasts of cross sector collaboration to solve national healthcare challenges.

Programme
16.00 Registration, coffee, tea

16.20 Welcome from the hosts

16.30 Clinical and patient context

Prof James Rowe, University of Cambridge

16.50 Bringing Academia and Industry together to overcome drug discovery challenges

Carol Routledge, ARUK

17.10 Innovation in Therapeutic Approach

Declan Jones, J&J Innovation

17.30 Neuroplasticity based Technology for Dementia

Kartheka Bojan, Cerebrum Matter

17.50 Linking therapeutics, device and digital technology for personalised care

Hakim Yadi, Closed Loop Medicine

18.10 Pitch session – this session will give the opportunity to up to 6 companies or research groups to pitch their innovative solution in the space of Dementia. If you would like to apply for a pitching slot please email dave.carter@eahsn.org

18.45 Closing remarks

19.00 Drinks and networking

20.00 End

This event is free to attend, to register please click here.

If you would like to raise your profile at this event, there are limited sponsoring opportunities offered. Please contact dave.carter@eahsn.org for more information.